Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Moderna Looks for a Breakout in 2021

TheMotleyFool

0 0

Moderna (NASDAQ: MRNA) reported lackluster fourth quarter results, but that wasn't a big surprise since its coronavirus vaccine was only authorized by the Food and Drug Administration in December. This year, on the other hand, the biotech is expected to produce at least $18.4 billion in revenue based on currently contracted sales. In this video from Motley Fool Live, recorded on March 1, Fool.com Contributors Brian Orelli and Keith Speights discuss Moderna's prospects and what it will take for the company to grow into its current valuation.

Source Fool.com

Like: 0

MRNA

Share